Other Names: [Ruminococcus] gnavus ATCC 29149 Ruminococcus gnavus Ruminococcus gnavus Moore et al. 1976 VPI C7-9
Change Display Name to
Source | Percentage | samples |
---|---|---|
SequentiaBiotech | 53.84615384615385 % | 39 |
AmericanGut | 0 % | 18 |
uBiome | 0 % | 834 |
Thryve | 89.51612903225806 % | 372 |
BiomeSight | 99.33774834437087 % | 151 |
I want to know what End Products this bacteria produces
Possible Health Impacts |
I would like to know about this bacteria's
|
If you have multiples samples, there is a time line option, click here, pick your samples and then click [My Taxon Time Line]
Login to see more symptoms with Premium. PValue: a E-9 is stronger association then a E-5 or 0.0001
Medical Condition | Direction | PValue |
---|---|---|
Ankylosing spondylitis | High | 1 |
Atherosclerosis | High | 1 |
Autism | High | 1 |
Chronic Fatigue Syndrome | High | 1 |
Chronic Kidney Disease | High | 1 |
Coronary artery disease | High | 1 |
Crohn's Disease | High | 1 |
Generalized anxiety disorder | High | 1 |
IgA nephropathy (IgAN) | Low | 1 |
Inflammatory Bowel Disease | High | 1 |
Liver Cirrhosis | High | 1 |
ME/CFS without IBS | High | 1 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | High | 1 |
Systemic Lupus Erythematosus | High | 1 |
A P-value below 0.0001 is the recommended threshold. A larger R-Square valye means a stronger relationship. This is unpublished data using Properitary Artificial Intelligence.